- Home
- RAYA vs SLGL Comparison
RAYA vs SLGL Comparison
Compare RAYA & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAYA | SLGL |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 117.8M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RAYA | SLGL |
|---|---|---|
| Price | $4.16 | $44.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 28.1K | 16.0K |
| Earning Date | 04-17-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,101,325.00 | $18,970,000.00 |
| Revenue This Year | $20.95 | $121.82 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.78 | ★ 62.04 |
| 52 Week Low | $3.13 | $4.02 |
| 52 Week High | $736.99 | $52.26 |
Technical Indicators
Market Signals| Indicator | RAYA | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 46.80 | 53.60 |
| Support Level | $4.20 | $38.91 |
| Resistance Level | $4.50 | $43.12 |
| Average True Range (ATR) | 0.47 | 3.32 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 17.77 | 51.15 |
Price Performance
Historical ComparisonAbout RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.